These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33488974)

  • 1. Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ Inhibitors.
    Bandarage UK; Aronov AM; Cao J; Come JH; Cottrell KM; Davies RJ; Giroux S; Jacobs M; Mahajan S; Messersmith D; Moody CS; Swett R; Xu J
    ACS Med Chem Lett; 2021 Jan; 12(1):129-135. PubMed ID: 33488974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphoinositide 3-kinase gamma (PI3Kgamma) inhibitors for the treatment of inflammation and autoimmune disease.
    Venable JD; Ameriks MK; Blevitt JM; Thurmond RL; Fung-Leung WP
    Recent Pat Inflamm Allergy Drug Discov; 2010 Jan; 4(1):1-15. PubMed ID: 20017720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Potent and Selective 7-Azaindole Isoindolinone-Based PI3Kγ Inhibitors.
    Miles DH; Yan X; Thomas-Tran R; Fournier J; Sharif EU; Drew SL; Mata G; Lawson KV; Ginn E; Wong K; Soni D; Dhanota P; Shaqfeh SG; Meleza C; Chen A; Pham AT; Park T; Swinarski D; Banuelos J; Schindler U; Walters MJ; Walker NP; Zhao X; Young SW; Chen J; Jin L; Leleti MR; Powers JP; Jeffrey JL
    ACS Med Chem Lett; 2020 Nov; 11(11):2244-2252. PubMed ID: 33214836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gamma.
    Pomel V; Klicic J; Covini D; Church DD; Shaw JP; Roulin K; Burgat-Charvillon F; Valognes D; Camps M; Chabert C; Gillieron C; Françon B; Perrin D; Leroy D; Gretener D; Nichols A; Vitte PA; Carboni S; Rommel C; Schwarz MK; Rückle T
    J Med Chem; 2006 Jun; 49(13):3857-71. PubMed ID: 16789742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of PI3Kγ selective inhibitors: the strategies and application.
    Gu DY; Zhang MM; Li J; Zhou YB; Sheng R
    Acta Pharmacol Sin; 2024 Feb; 45(2):238-247. PubMed ID: 37803138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ (PI3Kγ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS).
    Come JH; Collier PN; Henderson JA; Pierce AC; Davies RJ; Le Tiran A; O'Dowd H; Bandarage UK; Cao J; Deininger D; Grey R; Krueger EB; Lowe DB; Liang J; Liao Y; Messersmith D; Nanthakumar S; Sizensky E; Wang J; Xu J; Chin EY; Damagnez V; Doran JD; Dworakowski W; Griffith JP; Jacobs MD; Khare-Pandit S; Mahajan S; Moody CS; Aronov AM
    J Med Chem; 2018 Jun; 61(12):5245-5256. PubMed ID: 29847724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting phosphoinositide 3-kinase gamma to fight inflammation and more.
    Barberis L; Hirsch E
    Thromb Haemost; 2008 Feb; 99(2):279-85. PubMed ID: 18278175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ).
    Mata G; Miles DH; Drew SL; Fournier J; Lawson KV; Mailyan AK; Sharif EU; Yan X; Beatty JW; Banuelos J; Chen J; Ginn E; Chen A; Gerrick KY; Pham AT; Wong K; Soni D; Dhanota P; Shaqfeh SG; Meleza C; Narasappa N; Singh H; Zhao X; Jin L; Schindler U; Walters MJ; Young SW; Walker NP; Leleti MR; Powers JP; Jeffrey JL
    J Med Chem; 2022 Jan; 65(2):1418-1444. PubMed ID: 34672584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of PI3Kγ and δ Inhibitors for Inflammatory and Autoimmune Diseases.
    Perry MWD; Abdulai R; Mogemark M; Petersen J; Thomas MJ; Valastro B; Westin Eriksson A
    J Med Chem; 2019 May; 62(10):4783-4814. PubMed ID: 30582813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidyl Inositol 3 Kinase-Gamma Balances Antiviral and Inflammatory Responses During Influenza A H1N1 Infection: From Murine Model to Genetic Association in Patients.
    Garcia CC; Tavares LP; Dias ACF; Kehdy F; Alvarado-Arnez LE; Queiroz-Junior CM; Galvão I; Lima BH; Matos AR; Gonçalves APF; Soriani FM; Moraes MO; Marques JT; Siqueira MM; Machado AMV; Sousa LP; Russo RC; Teixeira MM
    Front Immunol; 2018; 9():975. PubMed ID: 29867955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI3Kgamma adaptor subunits define coupling to degranulation and cell motility by distinct PtdIns(3,4,5)P3 pools in mast cells.
    Bohnacker T; Marone R; Collmann E; Calvez R; Hirsch E; Wymann MP
    Sci Signal; 2009 Jun; 2(74):ra27. PubMed ID: 19509406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational Design of Novel Phosphoinositide 3-Kinase Gamma (PI3Kγ) Selective Inhibitors: A Computational Investigation Integrating 3D-QSAR, Molecular Docking and Molecular Dynamics Simulation.
    Li K; Zhu J; Xu L; Jin J
    Chem Biodivers; 2019 Jul; 16(7):e1900105. PubMed ID: 31111650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent discovery of phosphoinositide 3-kinase γ inhibitors for the treatment of immune diseases and cancers.
    Qiu X; Tian Y; Liang Z; Sun Y; Li Z; Bian J
    Future Med Chem; 2019 Aug; 11(16):2151-2169. PubMed ID: 31538525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Eucalyptin C, derived from the fruits of Eucalyptus globulus Labill., as a novel selective PI3Kγ inhibitor for immunosuppressive treatment.
    Hu XL; Shen W; Wang R; Long H; Wang Q; Feng JH; Pham TA; Xiong F; Ye WC; Wang H
    Chin J Nat Med; 2021 Nov; 19(11):844-855. PubMed ID: 34844723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoinositide 3-kinase gamma required for lipopolysaccharide-induced transepithelial neutrophil trafficking in the lung.
    Reutershan J; Saprito MS; Wu D; Rückle T; Ley K
    Eur Respir J; 2010 May; 35(5):1137-47. PubMed ID: 19797129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient targeting of phosphoinositide 3-kinase acts as a roadblock in mast cells' route to allergy.
    Collmann E; Bohnacker T; Marone R; Dawson J; Rehberg M; Stringer R; Krombach F; Burkhart C; Hirsch E; Hollingworth GJ; Thomas M; Wymann MP
    J Allergy Clin Immunol; 2013 Oct; 132(4):959-68. PubMed ID: 23683463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphoinositide 3-kinase γ plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice.
    Russo RC; Garcia CC; Barcelos LS; Rachid MA; Guabiraba R; Roffê E; Souza AL; Sousa LP; Mirolo M; Doni A; Cassali GD; Pinho V; Locati M; Teixeira MM
    J Leukoc Biol; 2011 Feb; 89(2):269-82. PubMed ID: 21048214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Potent and Selective PI3Kγ Inhibitors.
    Drew SL; Thomas-Tran R; Beatty JW; Fournier J; Lawson KV; Miles DH; Mata G; Sharif EU; Yan X; Mailyan AK; Ginn E; Chen J; Wong K; Soni D; Dhanota P; Chen PY; Shaqfeh SG; Meleza C; Pham AT; Chen A; Zhao X; Banuelos J; Jin L; Schindler U; Walters MJ; Young SW; Walker NP; Leleti MR; Powers JP; Jeffrey JL
    J Med Chem; 2020 Oct; 63(19):11235-11257. PubMed ID: 32865410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphoinositide-3 kinase gamma activity contributes to sepsis and organ damage by altering neutrophil recruitment.
    Martin EL; Souza DG; Fagundes CT; Amaral FA; Assenzio B; Puntorieri V; Del Sorbo L; Fanelli V; Bosco M; Delsedime L; Pinho JF; Lemos VS; Souto FO; Alves-Filho JC; Cunha FQ; Slutsky AS; Ruckle T; Hirsch E; Teixeira MM; Ranieri VM
    Am J Respir Crit Care Med; 2010 Sep; 182(6):762-73. PubMed ID: 20508212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration.
    Sasaki T; Irie-Sasaki J; Jones RG; Oliveira-dos-Santos AJ; Stanford WL; Bolon B; Wakeham A; Itie A; Bouchard D; Kozieradzki I; Joza N; Mak TW; Ohashi PS; Suzuki A; Penninger JM
    Science; 2000 Feb; 287(5455):1040-6. PubMed ID: 10669416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.